Osaic Holdings’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.48K Hold
968
﹤0.01% 6579
2025
Q1
$2.13K Hold
968
﹤0.01% 6445
2024
Q4
$1.48K Sell
968
-441
-31% -$673 ﹤0.01% 6573
2024
Q3
$2.8K Sell
1,409
-265
-16% -$527 ﹤0.01% 6322
2024
Q2
$5.86K Sell
1,674
-15,508
-90% -$54.3K ﹤0.01% 5994
2024
Q1
$47.6K Buy
17,182
+1,008
+6% +$2.79K ﹤0.01% 4773
2023
Q4
$27.5K Sell
16,174
-2,984
-16% -$5.07K ﹤0.01% 5297
2023
Q3
$19.7K Sell
19,158
-259
-1% -$267 ﹤0.01% 5547
2023
Q2
$22.5K Sell
19,417
-1,571
-7% -$1.82K ﹤0.01% 5469
2023
Q1
$31.7K Sell
20,988
-600
-3% -$906 ﹤0.01% 5265
2022
Q4
$54.5K Buy
21,588
+1,341
+7% +$3.39K ﹤0.01% 4861
2022
Q3
$85K Sell
20,247
-755
-4% -$3.17K ﹤0.01% 4501
2022
Q2
$58K Buy
21,002
+847
+4% +$2.34K ﹤0.01% 4838
2022
Q1
$115K Sell
20,155
-652
-3% -$3.72K ﹤0.01% 4490
2021
Q4
$189K Sell
20,807
-21,684
-51% -$197K ﹤0.01% 3996
2021
Q3
$456K Buy
42,491
+548
+1% +$5.88K ﹤0.01% 3120
2021
Q2
$652K Buy
41,943
+10,308
+33% +$160K ﹤0.01% 2739
2021
Q1
$513K Buy
31,635
+21,039
+199% +$341K ﹤0.01% 2838
2020
Q4
$223K Buy
10,596
+2,101
+25% +$44.2K ﹤0.01% 3373
2020
Q3
$126K Sell
8,495
-223
-3% -$3.31K ﹤0.01% 3621
2020
Q2
$128K Buy
8,718
+6,750
+343% +$99.1K ﹤0.01% 3495
2020
Q1
$23K Buy
+1,968
New +$23K ﹤0.01% 4502